Tafluprost eye drop and preparation method thereof

A technology of tafluprost and eye drops, applied in the field of medicine, can solve the problems of poor water solubility, poor stability and low solubility of tafluprost, and achieve the effects of improving curative effect, reasonable preparation process and easy operation.

Active Publication Date: 2016-03-09
苏州工业园区天龙制药有限公司
View PDF2 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] In view of the poor water solubility and stability of tafluprost, the object of the present invention is to provide a stable tafluprost-containing Eye drops of prostaglandin and preparation method thereof, thereby solving the problem of low solubility of tafluprost in the preparation process, improving the stability of tafluprost in aqueous solution and reducing the formation of related substances, so as to achieve safety , the purpose of effective treatment of glaucoma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tafluprost eye drop and preparation method thereof
  • Tafluprost eye drop and preparation method thereof
  • Tafluprost eye drop and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] prescription:

[0029]

[0030] Preparation Process:

[0031] Weigh polyethylene glycol-15-hydroxystearate and dissolve in water for injection, add tafluprost, stir to dissolve; take glycerin, EDTA-2Na, benzalkonium chloride, disodium hydrogen phosphate and dissolve in boiling In water for injection, stir to dissolve; after cooling to room temperature, combine the two liquids, filter, dilute with water for injection to prepare the full amount, adjust the pH value to 6.0, filter through a 0.22μm microporous membrane, and aseptically fill in plastic eye drops In a water bottle, that is.

Embodiment 2

[0033] prescription:

[0034]

[0035]

[0036] Preparation Process:

[0037] Weigh polyethylene glycol-15-hydroxystearate and dissolve in water for injection, add tafluprost, stir to dissolve; take sodium chloride, EDTA-2Na, benzalkonium chloride, disodium hydrogen phosphate and dissolve in In boiling water for injection, stir to dissolve; after cooling to room temperature, combine the two liquids, filter, dilute with water for injection to prepare the full amount, adjust the pH value to 6.0, filter through a 0.22μm microporous membrane, and aseptically fill in plastic Available in eye drops bottle.

Embodiment 3

[0039] prescription:

[0040]

[0041] Preparation Process:

[0042] Weigh polyethylene glycol-15-hydroxystearate and dissolve in water for injection, add tafluprost, stir to dissolve; take glycerin, EDTA-2Na, ethyl p-hydroxybenzoate, disodium hydrogen phosphate and dissolve in In boiling water for injection, stir to dissolve; after cooling to room temperature, combine the two liquids, filter, dilute with water for injection to prepare the full amount, adjust the pH value to 6.0, filter through a 0.22μm microporous membrane, and aseptically fill in plastic Available in eye drops bottle.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a tafluprost eye drop and a preparation method thereof. The eye drop takes tafluprost as an active ingredient and also contains a non-ionic solubilizer and a pharmaceutically acceptable carrier, wherein the non-ionic solubilizer is polyethylene glycol-15-hydroxyl stearate. According to the invention, the problem of low solubility of tafluprost in the preparation process can be solved, the stability of tafluprost in an aqueous solution can be increased, and formation of related substances is reduced.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to a new prostaglandin anti-glaucoma drug preparation, in particular to a tafluprost eye drop and a preparation method thereof. Background technique [0002] Glaucoma is a type of eye disease in which high intraocular pressure (IOP) causes damage to the optic nerve. It is the second most common cause of blindness and the leading cause of irreversible blindness in the world. At present, the treatment concept of glaucoma is aimed at reducing IOP, and the advent of new drug prostaglandin derivatives with high efficiency and no side effects has brought good news to glaucoma patients. Prostaglandin drugs are becoming more and more popular among patients due to their good effect of lowering intraocular pressure and excellent safety. The domestically marketed prostaglandin drugs include latanoprost, travoprost and tafluprost. [0003] Tafluprost is a selective FP prostaglandin receptor agon...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K31/216A61K47/34A61P27/06
CPCA61K9/0048A61K9/08A61K31/216A61K47/14
Inventor 侯宇华
Owner 苏州工业园区天龙制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap